摘要
变应性鼻炎(AR)是一种慢性非特异性鼻黏膜炎性病变,属于Ⅰ型变态反应,是一个全球性健康问题,可导致许多疾病和劳动力丧失,给社会带来的负担也越来越重。其发病过程中所包括的免疫细胞受到了不同的基因组的调控作用。现已有研究论证T细胞免疫球蛋白黏蛋白结构域分子-3(Tim-3)参与到免疫细胞的表达中,对很多免疫反应都有调节作用,与免疫系统疾病密切相关。目前针对变应性鼻炎的药物及治疗方法存在一定的局限性,因此找到更多有效的治疗方法刻不容缓。关于Tim-3在变应性鼻炎中的作用机制的相关研究很多,但其综述却是匮乏的,希望该文章,希望能丰富AR的免疫调控机制研究,并且为其治疗方法提供新的思路。
Allergic rhinitis(AR)is a chronic,non-specific inflammatory disease of the nasal mucosa.As a Type I hypersensitivity reaction,it leads to several diseases and labor losses and is a global health problem that burdens society.Different proteins,including Tim-3,regulate the immune cells that are involved in the pathogenesis of AR.Tim-3 has been demonstrated to be involved in immune cell expression and has a regulatory effect on several immune responses.Thus,it is also closely related to disorders of the immune system.Presently,the treatment options and medications for AR are limited,and it require more effective therapeutic interventions.While there are several studies on Tim-3’s mechanism of action in AR,a review of the available literature is lacking.This article aims to enrich the body of research on the immune regulation mechanism behind AR and provide new ideas for its treatment.
作者
向浏岚(综述)
叶远航(综述)
蒋璐云(审校)
刘洋(审校)
XIANG Liulan;YE Yuanhang;JIANG Luyun;LIU Yang(Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,Sichuan,China;Department of Otorhinolaryngology,Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,Sichuan,China)
出处
《山东大学耳鼻喉眼学报》
CAS
2020年第6期118-122,共5页
Journal of Otolaryngology and Ophthalmology of Shandong University
基金
国家自然科学基金(81774131,81603492)
2019年度中央引导地方发展专项(19ZYCXSF0065)
四川省科技厅科技支撑计划(2016FZ0094)
成都中医药大学“杏林学者”学科人才科研提升计划(青年学者)(QNXZ2019016)。
